Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Hemoglobin demonstrated

After these reports there were many attempts to administer hemoglobin solutions to humans. Many of these patients did well, but others demonstrated hypertension, bradycardia, oliguria, and even anaphylaxis. These untoward effects were not correlated with specific biochemical properties of the solutions themselves. [Pg.161]

The Jing group investigated their poly(L-lysine)-6-poly(L-phenylalanine) vesicles for the development of synthetic blood, since PEG-lipid vesicles were previously used to encapsulate hemoglobin to protect it from oxidation and to increase circulation time. They extended this concept and demonstrated that functional hemoglobin could be encapsulated into their vesicles. The same polypeptide material was also used to complex DNA, which caused the vesicles to lose their... [Pg.130]

Y-chains which differ from the 3-chalns In 39 positions The formula of Hb-F can be written as a2Y2 A minor hemoglobin fraction, Hb-Fi, which Is present for about 7 to 10 percent In a cord blood sample, has the structure of U2Y2 y Indicating that the NH2 terminal glycyl residue of the y-chaln Is acetylated Recently the existence of two structurally different Y-chalns has been demonstrated these two chains (the -and differ at a minimum In one position, namely... [Pg.5]

Hematological Methods. Hematological analyses can Include the determination of the total hemoglobin concentration (In g%), the packed cell volume (PCV In %), the red blood cell count (In 10 /mm ) and reticulocytes count (In %), calculation of the red cell Indices, examination of a blood film, tests to demonstrate the presence of Inclusion bodies and of sickle cells, tests to evaluate the distribution of fetal hemoglobin (Hb-F) Inside the red cells, the red cell osmotic fragility, the concentration of serum Iron (SI), total Iron binding capacity (TIBC), and the survival time of the red cells. Details of all... [Pg.9]

An Increased dissociation of the hemoglobin molecule to monomers can be demonstrated after treatment with p-chloromer-curlbenzoate often, the unstable subunit will precipitate Irreversibly. [Pg.30]

Structural Analyses of Hemoglobin Variants It has become Impossible to characterize nearly any abnormal hemoglobin by Its electrophoretic and/or chromatographic mobility only This Is most strikingly demonstrated by the fact that over fifty different variants behave similar to Hb-S In electrophoresis Characterization, therefore, often requires detailed structural analyses or the demonstration of a property unique to a specific variant Some of the techniques used In these studies will be... [Pg.34]

The presence of Individual chains In a hemoglobin variant can also be demonstrated by electrophoresis at alkaline pH after the protein has been dissociated Into Its subunits through exposure to 6 M urea In the presence of 3-mercaptoethanol. The buffer is either a barbital buffer or a tris-EDTA-boric acid buffer, pH 8.0 - 8.6, and contains 6 M urea and 3-niercapto-ethanol. Dissociation of the hemoglobin Into subunits Is best accomplished In a mixture of 1 ml 10 g% Hb (or whole hemolysate), 4 ml 6 M urea barbital or tris-EDTA-boric acid buffer, and 1 to 1.5 ml 3-mercaptoethanol. After 30 minutes to 1 hour the sample Is subjected to cellulose acetate or starch gel electrophoresis. Each chain has a specific mobility and an alteration In electrophoretic mobility easily Identifies the abnormal chain. [Pg.36]

Fetal hemoglobin (HbF) induction in patients with SCD, especially those with frequent crises, has been shown to decrease RBC sickling and RBC adhesion. A direct relationship between HbF concentrations and the severity of disease have been demonstrated in studies.3... [Pg.1012]

Hydroxyurea reduced the frequency of hospitalizations and the incidences of pain, acute chest syndrome, and blood transfusions by almost 50% in a landmark trial in adult SCD patients with moderate to severe disease. Hemoglobin and HbF concentrations increased, and hemolysis decreased.22 A follow-up study demonstrated a 40% reduction in mortality over a 9-year period in patients continuing to receive hydroxyurea.23 Not all patients responded equally, so hydroxyurea may not be the answer for all patients. [Pg.1012]

Hematological effects were noted in several animal studies. A few instances of significant differences were noted in the hematocytology (red blood cell [RBC] count, packed cell volume, hemoglobin, leukocyte count, and differential leukocyte count) in rats that had received diisopropyl methylphosphonate in the diet at doses of 0, 30, 100, or 300 mg/kg/day for 90 days. However, because the differences were so scattered and lacked clear dose response, they were considered of no toxicological importance (Hart 1976). Beagles that had been treated with the compound in the diet at doses of 4, 13, or 38 mg/kg/day for 14 days demonstrated values that were within normal limits for... [Pg.48]

Theoretical and model analysis based on a nanofluidic approach is needed for this situation. One may ask, is it possible to release proteins loaded in nanotubules We have found that the addition of the polycation PEI in the release solvent resulted in much quicker protein release, as demonstrated in Figure 14.9. In this case, most of the insulin was released in 1 hour instead of 100 hours. 10-40% of glucose oxidase, catalyse, and hemoglobin were released within 4 hours through complexation with PEI. It is unclear, whether the proteins were replaced by the polycation or released in a complex with PEI. [Pg.428]

FIGURE 8.5 Multiple-sensor respirometry. Representative calibration traces of PNOS (thin line, left ordinate) and PHSS (thick line, right ordinate) operating simultaneously in PBS, pH 7.3 at 37°C, with 50pM DTPA in a closed chamber respirometer. After NO additions were made, the chamber solution was replaced with fresh buffer, to which Na2S stock solutions were then injected in a stepwise manner. The stable POS signal shown at 2 pM 02 demonstrates that the POS does not respond to NO or H2S. Injections of anoxic buffered NO and H2S stocks are shown with concentrations at arrows, as are additions of Lucina pectinata ferric hemoglobin I (metHb I), which stoichiometrically binds to H2S (after [41]). [Pg.248]

Perhaps the most physiologically important metalloprotein to be S-nitrosated by NO is hemoglobin (Hb). The S-nitrosation of Hb-Cys 93 by NO was first demonstrated by Stamler and coworkers in 1996 (Jia et al., 1996 Stamler et al., 1997). To this day HbSNO remains controversial with respect to its mechanism of formation and physiological relevance. [Pg.95]

T3. Tuttle, A. H., Demonstration of hemoglobin-reactive substances in human serum. Science 121, 701 (1955). [Pg.187]


See other pages where Hemoglobin demonstrated is mentioned: [Pg.327]    [Pg.327]    [Pg.162]    [Pg.163]    [Pg.167]    [Pg.180]    [Pg.5]    [Pg.11]    [Pg.26]    [Pg.27]    [Pg.28]    [Pg.36]    [Pg.87]    [Pg.336]    [Pg.354]    [Pg.49]    [Pg.50]    [Pg.86]    [Pg.712]    [Pg.196]    [Pg.124]    [Pg.463]    [Pg.252]    [Pg.87]    [Pg.501]    [Pg.583]    [Pg.698]    [Pg.705]    [Pg.924]    [Pg.951]    [Pg.117]    [Pg.272]    [Pg.313]    [Pg.350]    [Pg.172]    [Pg.173]    [Pg.410]    [Pg.975]   


SEARCH



Demonstration

Demonstrators

© 2024 chempedia.info